neurapas
Botanicalexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2001 (NCT00997490)
Timeline
Indications
Mechanism of action
- Melatonin receptorINHIBITOR
Melatonin receptor inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- neurapas
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01047605 | Phase 1 | Jan 1, 2010 | Neurocode AG, Pascoe Pharmazeutische Praeparate GmbH |
| NCT00997256 | Phase 1 | Dec 1, 2004 | Pascoe Pharmazeutische Praeparate GmbH, Philipps University of Marburg |
| NCT00997490 | Phase 3 | Jan 1, 2001 | Pascoe Pharmazeutische Praeparate GmbH |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pascoe Pharmazeutische Praeparate GmbH | For profit | 3 | 3 | 2 | 2001 |
| Neurocode AG | For profit | 1 | 0 | 1 | 2010 |
| Philipps University of Marburg | Academic/Hospital | 1 | 0 | 1 | 2004 |
3 organizations
Page 1 / 1